Invited Speakers
The 2026 program committee has prepared a dynamic and engaging program, with distinguished and renowned speakers from across the globe, reflecting INS' commitment to international and interdisciplinary collaboration and in keeping with this year's theme, Neuropsychology in the Age of Innovation. Read more about our invited speakers below.
Invited sessions below are open to all attendees. Most are available for optional continuing education (CE) credit. To obtain the CE, you must pay a separate registration fee and attend the entire session (a volunteer proctor will distribute attendance slips at the door).
2026 Keynote Speakers
PLENARY A
Vince Calhoun, PhD
TReNDS Center @ {Georgia State University, Georgia Institute of Technology, and Emory University}, Georgia, USA
INS Capstone Lecture: Neuroimaging in the Age of Innovation
Wednesday February 4 | 4:30-5:30 PM
Plenary A: INS Capstone Lecture
Neuroimaging in the Age of Innovation
1 Hour CE Credit | Introductory Level
Learning Objectives
- Describe emerging trends in neuroimaging analysis that emphasize preserving data fidelity, interpretability, and hybrid modeling.
- Explain how frameworks such as NeuroMark integrate domain knowledge with adaptive, data-driven discovery.
- Discuss how innovations in dynamic modeling, multimodal fusion, and NeuroAI are shaping the future of translational neuroimaging and neuropsychology.
PLENARY B
Natalia Ojeda del Pozo, PhD
Deusto University, Spain
INS Presidential Lecture: Developments in the Diagnosis and Treatment of Cognitive Deficits in Schizophrenia: Past, Present and Future
Thursday February 5 | 10:45-11:40 AM
Plenary B (INS Presidential Lecture)
Developments in the Diagnosis and Treatment of Cognitive Deficits in Schizophrenia: Past, Present and Future
1 Hour CE Credit | Intermediate Level
Learning Objectives
- Recognize the cognitive déficit profile in people diagnosed with schizophrenia and its role in the course of the illness.
- Identify evidenced based treatments designed for coping with the neuropsychological déficits and the benefits of its implementation.
- Guide persons with the diagnosis of schizophrenia to neuropsychological rehabilitation for better clinical and functional outcomes.
PLENARY C
Albert "Skip" Rizzo, PhD
University of Southern California, USA
Clinical Virtual Reality:
A Brief Review of the Future
Thursday February 5 | 5:30-6:30 PM
Plenary C
Clinical Virtual Reality: A Brief Review of the Future
1 Hour CE Credit | Intermediate Level
Learning Objectives
- The learner will be able to describe the definition of Virtual Reality (VR) and the different ways that people can engage and interact with VR environments.
- The learner will be able to explain the specific rationales for the use of VR for assessment and intervention across a wide range of clinical disorders (i.e., ADHD, PTSD, Alzheimer's, Phobias, Stroke, addictions, etc.). Additionally, the learner will understand the theoretical and research support for the use of VR in clinical populations.
- The learner will be able to understand the relevant issues involved in the informed and ethical design, development, implementation, and evaluation of virtual environments, artificial intelligence, and virtual humans for use in clinical assessment and intervention.
PLENARY D
Mónica Rivera Mindt, PhD
Fordham University, New York, USA
Redefining the Field: Community-Engaged Research as a Catalyst for Neuropsychological Innovation
Friday February 6 | 9:00-10:00 AM
Plenary D
Redefining the Field: Community-Engaged Research as a Catalyst for Neuropsychological Innovation
1 Hour CE Credit | Intermediate Level
Learning Objectives
- Explain the need for more generalizable neuropsychological science across the adult lifespan.
- Summarize how a community engaged research approach can be applied to innovate and advance neuropsychological science.
- Describe examples of community-engaged research in action through findings from cognitive aging and Alzheimer’s and related dementias studies conducted within community settings.
- Delineate strategies to increase community engaged research capacity for the field of neuropsychology.
PLENARY E
Martin Sliwinski, PhD
The Pennsylvania State University, USA
Measuring a Moving Target: Ambulatory Methods for Capturing Cognitive Change in Daily Life
Friday February 6 | 11:45 AM-12:45 PM
Plenary E
Measuring a Moving Target: Ambulatory Methods for Capturing Cognitive Change in Daily Life
1 Hour CE Credit | Intermediate Level
Learning Objectives
- Explain how ambulatory methods extend traditional neuropsychological assessment by capturing short-term variability, learning effects, and contextual influences on cognition.
- Describe key design, analytic, and data-interpretation strategies for developing, implementing, and evaluating ambulatory cognitive assessments, including considerations for sampling, task design, and modeling within-person change.
- Apply principles of ambulatory assessment to plan and implement real-world research or clinical projects that use repeated, context-sensitive cognitive measurement.
PLENARY F
Vidyulata Kamath, PhD
The Johns Hopkins University School of Medicine, USA
The Clinical Utility of Olfactory Assessment in Neuropsychology
Friday February 6 | 5:00-6:00 PM
Plenary F
The Clinical Utility of Olfactory Assessment in Neuropsychology
1 Hour CE Credit | Introductory Level
Learning Objectives
- Describe the neuroanatomy and key features of the olfactory system
- Explain ways to assess and interpret olfactory performance clinically and integrate olfactory assessment tools into comprehensive neuropsychological evaluations
- Demonstrate the clinical utility of olfactory assessment in major neurodegenerative and neuropsychiatric conditions
PLENARY G
Alvaro Pascual-Leone, MD, PhD
Harvard Medical School, Massachusetts, USA
Methods and Effects of Neuromodulation
Saturday February 7 | 10:30-11:30 AM
Plenary G
Personalized Precision Neuromodulation
1 Hour CE Credit | Intermediate Level
Learning Objectives
- Discuss the use of neurotechnologies to capture digital biomarkers of cognitive performance and behavior across the lifespan to enable deep insights into an individual’s state of brain health, and allow for true precision health for the brain
- Introduce and illustrate the use of perturbation biomarkers integrating noninvasive brain stimulation approaches with imaging and neurophysiologic methods as toy models of the response of the individual nervous system to stressors, insults or injuries
- Describe the use of brain physiology-guided neuromodulation methods to modify brain spatio-temporal signatures of disability and offer personalized and targeted therapeutic interventions
- Demonstrate the availability of noninvasive brain stimulation methods capable of selective, and precise targeting of deep brain structures and multi-focal network modulation
- Raise the use of AI-driven, closed-loop learning systems to ensure iterative optimization of therapeutic algorithms.
Invited Symposia
Invited Symposium 1
Advocacy Across the Neuropsychological Spectrum
Led by Dr. Mirella Diaz-Santos, this symposium examines advocacy has both a safeguard for scientific integrity and a catalyst for equity injustice across research, clinical practice, and training.
Wednesday February 4 | 2:30-4:00 PM
Invited Symposium 1
Protecting Science, Promoting Brain Health: Advocacy Across the Neuropsychological Spectrum
1.5 Hours CE Credit | Intermediate Level
Learning Objectives
- Define key dimensions of advocacy and ethical responsibility in neuropsychology.
- Describe strategies to integrate advocacy into research, clinical, and educational systems.
- Identify practical approaches to promote scientific integrity, public trust, and equity in the field.
Invited Symposium 2
Use of Ecological Momentary Assessment in Neuropsychology
Dr. Philip Harvey will lead a session featuring international experts exploring how EMA is advancing our understanding of real-world cognitive and emotional functioning.
Thursday February 5 | 9:00-10:30 AM
Invited Symposium 2
Digital Phenotyping as the next Generation Strategy for Neuropsychological Assessment: Remote Cognitive Assessment, Active and Passive Digital Phenotyping and Their Integration and Synergy
1.5 Hours CE Credit | Intermediate Level
Learning Objectives
- Describe the characteristics and benefits of remote digital cognitive testing and active and passive digital phenotyping compared to traditional cognitive assessment strategies across multiple neuropsychiatric conditions.
- Evaluate the clinical utility of mobile assessments for early detection of cognitive decline as well as collecting information about capability for self-assessment and potential for treatment engagement.
- Choose a suitable digital assessment strategy for use in their clinical populations and select the necessary additional factors to evaluate in such as interaction with environmental factors or momentary mood states
Invited Symposium 3
Neuromodulation Based Interventions
Dr. Benjamin Hampstead will lead a session on cognition and neuromodulation based interventions, exploring the cutting edge of nonpharmacologic treatment strategies for cognitive and functional impairments.
Thursday February 5 | 4:00-5:25 PM
Invited Symposium 3
Current Evidence and Methodological Advances for Transcranial Direct Current Stimulation
1.5 Hours CE Credit | Introductory Level
Learning Objectives
- Describe the benefits and limitations of using computational modeling to plan and/or assess the effects of transcranial direct current stimulation (tDCS)
- Describe potential uses for, and evidence supporting, tDCS and high-definition (HD-)tDCS in both cognitively intact adults and patient populations.
- Understand how to apply (HD-)tDCS to address clinical symptoms in patient populations.
Invited Symposium 4
Women Leaders in Neuropsychology
Join us for an engaging conversation with prominent women leaders from around the world. Featured speakers include Dr. Natalia Ojeda Del Pozo (President of INS), Dr. Mary Kosmidis (President-Elect of INS), Dr. Lisa Cipolotti (President of FESN), and others who have shaped the field through research, mentorship, and leadership.
Invited Symposium 5
Keeping the Main Thing the Main Thing
Drs. Russ Bauer and Joel Kramer will lead a reflective session on the legacy and evolving future of neuropsychology. They will discuss how the field's foundational traditions can inform the future of the field especially as we look to integrate innovative methods, emerging technologies, and large language models.
Friday February 6 | 3:30-4:55 PM
Invited Symposium 5
Keeping the Main Thing the Main Thing
1.5 Hours CE Credit | Introductory Level
Learning Objectives
- Participants will be able to identify three elements of common neuropsychological practice that slow neuropsychology's ability to adapt to changes in health care and neuroscience
- Participants will be able to describe specific steps that neuropsychology can take to better incorporate a global health perspective
- Participants will build concrete ways to incorporate the classic neuropsychological and neurobehavioral classis into existing training programs
Invited Symposium 6
Invited Special Interest Group Symposium
The Program Co-Chairs have invited the 13 Special Interest Groups (SIGs) of INS to submit symposium proposals that highlight topics central to their SIG’s mission and examine their intersection with the 2026 conference theme, Neuropsychology in the Age of Innovation. Stay tuned on this!